Trials / Terminated
TerminatedNCT05964452
Efficacy of Methimazole Dosing Algorithm
The Efficacy of Cook County Health's Methimazole Dosing Algorithm in the Setting of Ne Onset Graves' Hyperthyroidism
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 11 (actual)
- Sponsor
- Cook County Health · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To prospectively study the efficacy and safety of the Cook County Health (CCH) methimazole (MMI) dosing algorithm in the setting of new onset Graves' disease.
Detailed description
To conduct a prospective observational study in 60 patients with newly diagnosed Graves' disease who are either methimazole naive or who have been initiated on MMI within previous 4-6 weeks per CCH algorithm and assess for efficacy and safety of MMI dosing administered. Study group size is based on 90% power and projected efficacy of 70% patients reaching target.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methimazole Tablets | Testing dosing algorithm for efficacy. |
Timeline
- Start date
- 2022-02-14
- Primary completion
- 2024-09-17
- Completion
- 2024-09-17
- First posted
- 2023-07-28
- Last updated
- 2024-12-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05964452. Inclusion in this directory is not an endorsement.